Add Formweb to your mobile device
LH Pharmacy and Therapeutics (P&T) Committee serves in an evaluative, educational, and advisory capacity to the medical staff and organizational administration in all matters pertaining to the use of drugs, including developing and updating the a formulary of drugs accepted for use in LH. See Mission, function, membership
Formulary addition request form (For physician use to request a medication be added to formulary)
| 2016 P&T Formulary Decisions | |
| September | No medication changes |
| August | Therapeutic Interchange: Topical Steroids approved |
| July | No meeting in July |
| June |
Mifepristone (Mifeprex) added to formulary with restriction to OB providers in Legacy Medical Group who have registered in REMS program. Sugammadex (Bridion) added to formulary with restriction to anesthesia providers for reversal of rocuronium or vecuronium. Tirofiban (Aggrastat) added to formulary to replace eptifibatide. Eptifibatide (Integrelin) removed from formulary. May be available for patients already started on eptifibatide. |
| May | Capsaicin 8% (Qutenza) added to formulary with restriction to Pain Clinic use only. |
| April |
Filgrastim (Neupogen) removed from formulary for adults. Remains formulary for pediatrics. tbo-filgrastim (Granix) added to formulary with therapeutic interchange from filgrastim. |
| March |
Netupitant/palonosetron (Akynzeo) not added to formulary. Aprepritant (Emend) added additional indications. Approved oral and suspension for chemotherapy induced nausea and vomiting only. Not reviewed for post-operative nausea and vomiting- non-formulary for this indication. Fosaprepitant added to formulary for oncology related nausea and vomiting. Palonosetron (Aloxin) added to formulary for oncology related nausea and vomiting. Pyridoxine/Doxylamine (Diclegis) not added to formulary. |
| February | No medication changes |
| January | Idarucizumb (Praxbind) added to formulary for reversal of Pradaxa only. |
Archive P&T Meeting Minutes (2013-2014)
Archive of prior Formulary Decisions (currently under construction on intranet)
The LH Pharmacy and Therapeutics (P&T) Committee is a medical staff committee consisting of membership from medical staff, pharmacy, patient care services, quality leadership and administration.